GSK Stockmann

GSK Stockmann advised Art-Invest Real Estate on the sale of the Momenturm office building, located in Munich’s Werksviertel district, to Generali. The European commercial law firm has provided ongoing support to Art-Invest Real Estate with the project since the initial acquisition of the property. Art-Invest Real Estate has sold the Momenturm project to Generali Deutschland. The transaction was carried out by Generali Real Estate S.p.A. on behalf of Generali Deutschland. The existing approx. 11,000 sqm of office space in the building, located at Rosenheimer Strasse 139, just a stone’s throw away from Munich Ostbahnhof, is to be extended to around 28,000 sqm. Generali Deutschland plans to use the building as its new corporate headquarters, with 1,500 employees expected to be relocated there. A GSK Stockmann team led by Munich-based partner Dirk Brückner has been providing Art-Invest Real Estate with comprehensive support on this project since it first acquired the property back in 2019. The firm’s advice encompassed project structuring, project development and securing planning permission, as well as the sale to Generali. Art-Invest Real Estate is a long-standing client of GSK Stockmann. Most recently, the law firm advised the company on the acquisition of a hotel portfolio in 2024, which included properties in Berlin, Oberhausen, Koblenz and Frechen near Cologne. Other past projects include the acquisition of the Wangen office campus in Stuttgart and the Arnulfbogen in Munich, both in 2021, as well as the commercial property F150 on the Frankfurter Ring in Munich and the City-Passage in Wiesbaden, both in 2022. Advisers of Art-Invest Real Estate at GSK Stockmann: Dr Dirk Brückner (lead), Dr Mark Butt (both Real Estate Transactions & Investments), Stefan Dorn (Project Development), Stefan Wachsmuth (Tax), Katharina Feierabend (Real Estate Transactions & Investments); Associates: Sebastian Gerhards (Tax), Maximiliane Bartsch, Melanie Patrizia Seitz (both Real Estate Transactions & Investments), Leonie Lindenbuß (Project Development) GSK München Contact: GSK STOCKMANN Dr Dirk Brückner Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174 - 71 F +49 89 288174-44 [email protected] Press contact: GSK STOCKMANN Christina Holl Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected]   GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind:  Your perspective. More about us: www.gsk.de  

European commercial law firm GSK Stockmann provided the Arsipa Group, backed by Warburg Pincus, with comprehensive legal advice on its acquisition of the Munich-based occupational healthcare provider Betriebsmedizin-23 GmbH. This represents a further step in Arsipa’s strategic expansion in the field of occupational medicine and also strengthens its presence in Bavaria. The acquisition provides a long-term succession solution for the well-established occupational medicine practice Betriebsmedizin-23, ensuring continuity of service for its clients in the greater Munich area. Under the management of Dr Markus Heyenbrock, the practice provides services primarily to small and medium-sized companies in the industrial, service, healthcare and public sectors. Its scope of services includes standard occupational health services, medical check-ups, vaccinations, advice on risk assessments and mental stress, as well as workplace integration management and occupational health and safety training. Following the acquisition, Betriebsmedizin-23 will benefit from the digital management solutions offered by the Arsipa Group, which will enable it to optimise its administrative processes and ultimately improve medical care. The acquisition takes the Arsipa Group’s network to over 60 locations serving more than 22,000 companies. A team led by Berlin-based partner Robert Korndörfer advised the Arispa Group on the acquisition. GSK Stockmann has a proven track record in providing expert advice on transactions in the healthcare sector, having previously advised Arsipa on its acquisition of the occupational healthcare provider Betriebsärzte Allgäu. Advisers of Arsipa at GSK Stockmann: Robert Korndörfer (lead, Corporate), Clara López Hernando (Corporate), Stephan Wachsmuth (Tax), Nicole Deparade (Employment Law), Katrin Zukovskaja (Employment Law), Dr Martin Hossenfelder (IP/IT), Dr Maximilian Schnebbe (Data Protection) Contact: GSK STOCKMANN Robert Korndörfer Anton-Wilhelm-Amo-Str. 42 10117 Berlin T +49 30 203907 - 93 F +49 30 203907-44 [email protected] Press contact: GSK STOCKMANN Christina Holl Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective. More about us: www.gsk.de

GSK Stockmann advised the Arsipa Group on the acquisition of Betriebsärzte Allgäu, a well-established occupational healthcare provider based in Kempten. This acquisition will expand Arsipa’s presence in one of the strongest economic regions in southern Germany. A GSK Stockmann team led by Berlin partner Robert Korndörfer provided the Arsipa Group with comprehensive legal advice on the merger with Betriebsärzte Allgäu. The merger was carried out as part of an orderly succession plan, with three of the four partner doctors gradually stepping down from their senior management positions. They will, however, continue to work for the company as medical practitioners. The Arsipa Group is a Warburg Pincus portfolio company specialising in occupational medicine, occupational safety, occupational psychology and environmental protection. It has around 750 employees across more than 50 locations in Germany and Austria and provides services to over 20,000 companies. Betriebsärzte Allgäu is a partnership company founded in 2015 and based in Kempten. The team looks after more than 600 companies in the Allgäu region, focusing on occupational medicine while also providing complementary services in specialised areas such as traffic medicine, allergology and holiday/travel medicine. The practice primarily works with companies in the transport, logistics and industrial sectors, as well as with public sector organisations such as the German Armed Forces. Advisers of Arsipa at GSK Stockmann: Robert Korndörfer (lead, Partner, Corporate), Stephan Wachsmuth (Local Partner, Tax), Nicole Deparade (Local Partner, Employment Law), Dr Martin Hossenfelder (Counsel, IP/IT), Clara López Hernando (Senior Associate, Corporate), Katrin Zukovskaja (Associate, Employment Law), Dr Maximilian Schnebbe (Associate, Data Protection) ### Contact: GSK STOCKMANN Robert Korndörfer Anton-Wilhelm-Amo-Str. 42 10117 Berlin T +49 30 203907 - 93 F +49 30 203907-44 [email protected] Press contact: GSK STOCKMANN Christina Holl Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective. More about us: www.gsk.de

In another significant strategic move, GSK Stockmann welcomes Simon Spangler as a new partner as of 1 August 2025. This new addition underlines the firm’s leading position in commercial law and transformation issues and will enhance its range of advisory expertise for national and international clients and projects. Dr Simon Spangler is a renowned expert in German and European antitrust law as well as in the areas of compliance and ESG. He specialises in providing antitrust and distribution law advice to companies in the technology, consumer goods and life sciences sectors. He also provides comprehensive advice on issues relating to the platform economy, private enforcement issues and merger control proceedings at the national and international level. In addition, he has many years of experience in related compliance issues, particularly in ESG compliance and internal investigations, as well as in state aid and subsidy law. Simon Spangler’s wealth of experience and in-depth expertise make him a valuable addition to GSK Stockmann’s Corporate team, where he will work closely with the firm’s IT and AI specialists to set new benchmarks in the field of digital economy and AI solutions and help to accelerate the firm’s growth. Simon Spangler is joining GSK Stockmann from Oppenhoff & Partner, where he has worked in the field of antitrust and state aid law since 2013, becoming a partner in January 2019. He will be accompanied by his colleague Renée Eckruth, who will join GSK Stockmann as a Senior Associate. “We are delighted to be welcoming a recognised expert like Simon Spangler to our team. His expertise and network will be a great asset and support the strategic development of our Corporate team. The addition of this new team ensures that we are now in an even stronger position to continue providing our clients with the best possible support with all kinds of complex matters in the future,” says Dr Justus Jansen, Managing Partner at GSK Stockmann. “Simon Spangler’s impressive range of expertise will be a valuable addition to our Corporate team in Germany, Luxembourg and London. Thanks to his extensive expertise in antitrust law and compliance advice, we can now offer the full scope of services in this area. This enables us to provide real added value to our clients and explore additional areas of advice with significant business development potential. His knowledge and many years of experience will help to strengthen and enhance our Corporate team in the long term,” comments Dr Katy Ritzmann, Head of GSK Stockmann’s Corporate division. Simon Spangler also sees great potential in his new role at GSK Stockmann: “I am very pleased to be able to put my expertise to good use at GSK Stockmann – especially in dynamic, future-oriented fields such as digitalisation and ESG. Together with the experienced team at GSK Stockmann, I am confident that I can provide our clients with bespoke, forward-thinking advice.” Press contact: GSK STOCKMANN Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective. More about us: www.gsk.de

Commercial law firm GSK Stockmann continues the strategic expansion of its Corporate team by welcoming Bernd Graßl as a partner at its Munich office with effect from 1 August 2025. The new addition highlights the firm’s leading position in European commercial law and will enhance its range of advisory expertise for listed companies and international cases, as well as in corporate litigation. Dr Bernd Graßl, formerly a partner at GLNS, has extensive expertise in stock corporation and capital markets law, public M&A and corporate law as well as in stock corporation and capital markets disputes and corporate litigation. His many years of experience and in-depth expertise make him a valuable addition to GSK Stockmann’s growing Corporate team. As a trusted expert in his field, Bernd Graßl will help to further strengthen the firm’s 360-degree advisory approach. This means that clients will benefit from even more comprehensive, customised solutions both in Germany and at GSK Stockmann’s international offices in Luxembourg and London. Bernd Graßl will bring fresh dynamism to the team, particularly when it comes to supporting capital market companies and advising on complex corporate law issues and the particularities of legal disputes involving listed companies. “With Bernd Graßl on board, we are ideally positioned to advise and represent clients in the currently recovering stock market environment. His broad expertise and experience are a valuable addition to our Corporate team, both throughout Germany and internationally,” says Dr Katy Ritzmann, Head of GSK Stockmann’s Corporate division, commenting on the arrival of the new partner. “His proven track record in stock corporation and capital markets law, as well as in IPOs for tech companies, makes him a real asset for our clients and our team. The firm will also benefit greatly from his experience in corporate litigation.” “Bernd Graßl’s expertise will enable us to provide our clients with even more comprehensive and strategic support in complex corporate law disputes,” adds Dr Justus Jansen, Managing Partner at GSK Stockmann. “His expertise complements our existing knowledge perfectly and will help us to continue to strengthen our position in the area of corporate litigation. This will allow us to offer our clients an even broader spectrum of high-quality advice – both here in Germany and internationally.” Bernd Graßl is looking forward to his new role: “GSK Stockmann stands for legal advice of the highest quality, entrepreneurial foresight and a strong international network. I am looking forward to working with a highly motivated team to develop innovative, bespoke solutions for our clients, as well as expanding the firm’s range of services throughout Europe.” Press contact: GSK STOCKMANN Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective. More about us: www.gsk.de

GSK Stockmann advised DZ HYP AG on the financing of the Upper West high-rise building in Berlin-Charlottenburg. The buyer is Schoeller Group GmbH, based in Pullach near Munich. Upper West is located directly on Berlin’s Breitscheidplatz, opposite Kaiser Wilhelm Memorial Church and just a stone’s throw from the city’s famous shopping boulevard, Kurfürstendamm. At around 120 metres high, it is one of the tallest buildings in Berlin. The building’s distinctive glass and steel façade makes it a striking part of the city’s skyline. The building also meets high standards in terms of urban development and sustainability. Upper West combines office and retail space, as well as a Motel One flagship hotel with 582 rooms over 19 floors. The building is DGNB Gold & LEED Platinum certified. A GSK Stockmann team led by Munich partner Alma Franke advised DZ HYP on financing the purchase transaction. Advisers of DZ HYP AG at GSK Stockmann: Dr Alma Franke (lead), Dr Mechtild-Maria Siebke, Marcel Buss, Beatrice Christina Dörr (all finance), Robert Korndörfer, Dr Raoul Kreide, Matti Kamer (both corporate), Stefan Schlapka (real estate law/hospitality), Andreas Heinzmann, Hawa Mahamoud, Eva Jean (corporate/finance, Luxembourg)

Labour and social security law expert Daniel Nerl has joined GSK Stockmann’s team in Luxembourg as local partner, where he will develop the firm’s new practice in that area. He joins from leading independent business and litigation law firm Kleyr Grasso – together with his Associate Julie Tisserand – and will work closely together with Counsel Marie-Therese Wich. Daniel Nerl has extensive experience in the fields of labour and social security matters. He has been advising clients since 2011 on the entire spectrum of human resources matters by offering a full-service approach from advisory on day-to-day matters (including on- and offboarding, due diligences, general corporate support, etc.) to litigation. In addition, he has been a lecturer for training organisms on HR matters for over 10 years. Daniel Nerl studied in France in Bordeaux and Paris at the Sorbonne and was admitted to the bar in Luxembourg in 2011; he is member of ELSA asbl – Employment Law Specialist Association Luxembourg. “We are pleased to welcome Daniel Nerl and Julie Tisserand to our team. Their strong experience in the field of labour law and litigation as well as their deep expertise of the Luxembourg market will benefit our international client base”, comments Andreas Heinzmann, Partner at GSK Stockmann in Luxembourg. “We are looking forward to working with the new team members who will further strengthen our international capabilities in labour law and litigation. We wish them a great start at GSK Stockmann”, adds Dr. Oliver Glück, Co-Managing Partner at GSK Stockmann. “I am thrilled to join GSK Stockmann in Luxembourg, together with my long-term colleague Julie Tisserand, and am looking forward to working with a strong team on challenging and complex projects”, says Daniel Nerl. The office of GSK Stockmann in Luxembourg opened in 2016 with four partners and has since grown to a team of more than 30 fee earners focussing on the field of Banking & Finance, Capital Markets, Corporate and M&A, Private Equity, Investment Funds, Real Estate, Regulatory, Insurance, and Tax. Press contact: GSK STOCKMANN Christina Holl Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective. More about us: www.gsk.de

GSK Stockmann, working with a team of other firms including Troutman Pepper Locke, advised global digital infrastructure company Colt Technology Services on the sale of six of its data centres to NorthC, a data centre operator headquartered in the Netherlands. As part of the deal, Colt will also divest two of its other data centres in London to NorthC’s majority owner DWS Group. The eight data centres included in the transaction are in Amsterdam, Berlin, ‎Düsseldorf, Frankfurt, Hamburg and Munich, as well as the two in London. The data centres were part of the ‎assets Colt gained with its acquisition of Lumen EMEA in 2023. GSK Stockmann, working with Troutman Pepper Locke and a team of further local counsel and instructed by Nadine Ramasamy, Alex Galtieri and Annarita Spena of Colt, advised on the German real estate aspects of the deal and also on Colt’s ongoing partnership with NorthC. Colt’s future relationship with NorthC will include Colt retaining network equipment in the divested data centres as part of its global digital ‎infrastructure, which connects 32,000 buildings, spans more than 40 countries, reaches more than 275 ‎points of presence, and includes 10 subsea cable systems‎. The transaction is expected to close in summer 2025. [caption id="attachment_48296" align="alignnone" width="300"] GSK Berlin[/caption] Advisers of Colt at GSK Stockmann: Dr Olaf Schmechel (lead partner, Real Estate/Data Centres), Çağlayan Birkan (Real Estate), Sören Wolkenhauer (Energy), Dr Jörg Kahler (IP/IT), Dr Anna Charlotte Kümpers (Public Law) Contact: GSK STOCKMANN Dr Olaf Schmechel Mohrenstrasse 42 10117 Berlin T +49 30 203907 - 0 F +49 30 203907-44 [email protected] Press contact: GSK STOCKMANN Christina Holl Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind:  Your perspective. More about us: www.gsk.de/en

GSK Stockmann has provided comprehensive legal advice to L-Rea GmbH on the establishment of a joint venture with the BlueRock Group AG regarding L-Rea GmbH’s subsidiary Residea Immobilien Management GmbH. Since April, the BlueRock Group AG, based in Zurich and Berlin, holds a stake in Residea Immobilien Management GmbH as part of a joint venture. A team led by Berlin based partner and Corporate/M&A specialist Dr. Thomas Derlin provided comprehensive legal support to L-Rea GmbH regarding this strategic partnership with BlueRock Group AG, in particular in the negotiations and conclusion of the share purchase agreement and the joint venture agreement as well as related corporate and commercial law issues. Residea Immobilien Management GmbH is a fully integrated asset management company, managing a portfolio of several thousand residential and commercial units, primarily in Berlin. For the real estate investor and asset manager BlueRock Group AG, the participation secures access to qualified management capacities in the demanding Berlin real estate market. [caption id="attachment_48294" align="alignnone" width="300"] GSK Berlin[/caption] Advisers of L-Rea at GSK Stockmann: Dr Thomas Derlin, Dr Andreas C. Peters (both lead, both Corporate/M&A), Dominik Berka (Tax), Jan Kramer (Real Estate) Christina Lorf (Corporate/M&A) Advisers of Blue Rock Group: Heussen Rechtsanwaltsgesellschaft mbH: Jan Dittmann, Johannes Weidelener Notary: Heuking Contact: GSK STOCKMANN Dr Thomas Derlin Mohrenstrasse 42 10117 Berlin T +49 30 203907 - 0 F +49 30 203907-44 [email protected] Press contact: GSK STOCKMANN Christina Holl Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind:  Your perspective. More about us: www.gsk.de/en